Monoclonal antibody prevented malaria in small NIH trial
On Aug. 11, 2021, the National Institutes of Health (NIH) announced that one dose of a new monoclonal…
-
-
NIH launched study of third COVID-19 vaccine dose in kidney transplant recipients
On Aug. 10, 2021, the National Institutes of Health (NIH) announced that a pilot study had begun to…
-
Oragenics entered into licensing agreement with the NRC of Canada, to pursue next-generation SARS-CoV-2 vaccines
On Jul. 27, 2021, Oragenics announced it had entered into a licensing agreement with the National Research Council…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | FDA | Infectious Disease | NIH | Non-Profit Research | Vaccine
The COVID-19 Vaccine
Cast of Characters: Jay Inslee, Governor, Washington | Anthony S. Fauci, MD, Director, National Institute of Allergy and…
-
Trevena announced first patient enrolled in NIH-funded ACTIV-4 host tissue trial of TRV027 for COVID-19
On Jul. 26, 2021, Trevena announced that the first COVID-19 patient had been enrolled in the NIH-funded ACTIV-4…
-
Biotechnology | Cartoons - Original | COVID-19 | Diagnostics | Infectious Disease | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | Vaccine
COVID-19 vacation Destinations
Planning a Summer vacation? Where to go? How about going to one of those large events with tens…
-
Biotechnology | HIV | NIH
NIH awarded more than $20 million to international HIV database centers
On Jul. 22, 2021, the National Institutes of Health announced it had renewed grants to seven regional centers…
-
NIH study associated COVID-19 surged with mortality increases for patients
On Jul. 8, 2021, the National Institutes of Health (NIH) announced that a new study authored by scientists…
-
Biotechnology | COVID-19 | Diagnostics | NIH
NIH-funded screening study builds case for frequent COVID-19 antigen testing
On Jun. 30, 2021, the National Institutes of Health (NIH) announced a highly anticipated study that compared rapid…
-
Fostamatinib selected for NIH ACTIV-4 COVID-19 clinical trial
On Jun. 29, 2021, Rigel Pharma announced that fostamatinib, the Company’s novel oral spleen tyrosine kinase (SYK) inhibitor,…
-
Adjuvant developed with NIH funding enhanced efficacy of India’s COVID-19 vaccine
On Jun. 29, 2021, the National Institutes of Health announced that an adjuvant developed with its funding had…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | FDA | Genomics | Life Science History | Medicine | NIH | Therapeutics | U.S. Congress | Vaccine
COVID-19 PPE distribution
Cast of Characters: Jay Inslee, Governor, Washington | Gavin Newsom, Governor, California | Doug Ducey, Governor, Arizona |…
-
KPWHRI announced volunteers needed for COVID-19 vaccine-booster trial
On Jun. 14, 2021, Kaiser Permanente Washington Health Research Institute (KPWHRI) announced that was recruiting volunteers in the…
-
Study suggested no association between antiseizure drugs used during pregnancy and neurodevelopmental problems in children at age 2
On Jun. 7, 2021, the National Institutes of Health announced new findings published in JAMA Neurology that suggested…
-
NIH researchers identified potential new antiviral drug for COVID-19
On Jun. 3, 2021, the National Institutes of Health (NIH) announced that the experimental drug TEMPOL may be…
-
NIH clinical trial evaluating mixed COVID-19 vaccine schedules began
On Jun. 1, 2021, the National Institutes of Health (NIH) announced that it had started a Phase 1/2…
-
HHS launched first venture capital partnership to develop transformative technologies to combat future pandemics
On Jun. 1, 2021, the U.S. Department of Health and Human Services (HHS) unveiled a new type of…
-
NIH launched clinical trial of universal influenza vaccine candidate
On Jun. 1, 2021, the National Institutes of Health (NIH) announced the first-in-human, Phase 1 trial assessing the…
-
Biotechnology | Diagnostics | FDA | Infectious Disease | NIH | Therapeutics
NIAID scientists found that Salmonella use intestinal epithelial cells to colonize the gut
On May 26, 2021, National Institutes of Health (NIH) scientists reported that the immune system’s attempt to eliminate…
-
Trevena announced TRV027 selected by NIH-funded ACTIV initiative for COVID-19 trial
On May 6, 2021, Trevena announced that TRV027, the Company’s novel AT1 receptor selective agonist, had been selected…
-
NIH announced investment of $29 million to address COVID-19 disparities
On Apr. 29, 2021, the National Institutes of Health announced it was funding $29 million in ad itional…
-
Biotechnology | Cartoons - Original | CDC | COVID-19 | Diagnostics | Medicine | NIH | Non-Profit Research | Pharmaceutical | Therapeutics | U.S. Congress | USDA | Vaccine | WHO
COVID-19 science and reason
COVID-19 and it’s naysayers are attacking Science and Reason. The defenders must suffer the slings and arrows from…
-
COVID-19 vaccine responses studied in people with immune deficits
On Apr. 23, 2021, the NIH announced that a study assessing how people with immune system deficiencies or…
-
Clinical trial of therapeutics for severely ill hospitalized COVID-19 patients began
On Apr. 22, 2021, the NIH announced that a phase 3 trial to test the safety and efficacy…
-
Large NIH clinical trial tested polyclonal antibody therapeutic for COVID-19
On Apr. 21, 2021, the NIH announced that a Phase 2/3 trial to evaluate a new fully-human polyclonal…
-
Tonix Pharma entered worldwide licensing agreement to develop antiviral SARS-CoV-2 inhibitor for treatment of COVID-19
On Apr. 19, 2021, Tonix Pharmaceuticals and OyaGen announced an exclusive worldwide licensing agreement for an antiviral inhibitor…
-
Large clinical trial launched to study repurposed drugs to treat COVID-19 symptoms
On Apr. 19, 2021, the NIH announced that it was funding a large, randomized, placebo-controlled Phase 3 clinical…
-
NIH funded new influenza research network
On Apr. 15, 2021, the National Institute of Allergy and Infectious Diseases (NIAID) announced it had established a…
-
Most differences in DNA binding compounds found at birth in children conceived by IVF not seen in early childhood
On Apr. 14, 2021, National Institutes of Health researchers reported that a study which compared to newborns conceived…
-
Positive topline data showed Fostamatinib met primary endpoint of safety in phase 2 clinical trial in hospitalized COVID-19 patients
On Apr. 13, 2021, Rigel Pharma announced the completion of patient enrollment in a multi-center Phase 2 clinical…
